Obesity as a correlate of outcome in patients with bipolar I disorder

被引:303
作者
Fagiolini, A [1 ]
Kupfer, DJ [1 ]
Houck, PR [1 ]
Novick, DM [1 ]
Frank, E [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Psychiat, Western Psychiat Inst & Clin, Pittsburgh, PA 15213 USA
关键词
D O I
10.1176/appi.ajp.160.1.112
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: This study sought to evaluate the relationship of obesity to demographic and clinical characteristics and treatment outcome in a group of 175 patients with bipolar I disorder who were treated for an acute affective episode and followed through a period of maintenance treatment. Method: Data were from participants entering the Maintenance Therapies for Bipolar Disorder protocol between 1991 and 2000. Analyses focused on differences in baseline demographic and clinical characteristics and in treatment outcomes between obese and nonobese patients. Results: A total of 35.4% of the patients met criteria for obesity. Significant differences between the obese and nonobese patients were observed for years of education, numbers of previous depressive and manic episodes, baseline scores on the Hamilton Rating Scale for Depression, and durations of the acute episode. A KaplanMeier survival analysis indicated a significantly shorter time to recurrence during the maintenance phase among obese patients. The number of patients experiencing a depressive recurrence was significantly higher in the obese than in the nonobese group. Conclusions: Obesity is correlated with a poorer outcome in patients with bipolar I disorder. Preventing and treating obesity in bipolar disorder patients could decrease the morbidity and mortality related to physical illness, enhance psychological well-being, and possibly improve the course of bipolar illness. Weight-control interventions specifically designed for patients with bipolar illness should be developed, tested, and integrated into the routine care provided for these patients.
引用
收藏
页码:112 / 117
页数:6
相关论文
共 27 条
[1]   Annual deaths attributable to obesity in the United States [J].
Allison, DB ;
Fontaine, KR ;
Manson, JE ;
Stevens, J ;
VanItallie, TB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (16) :1530-1538
[2]  
[Anonymous], 1997, WHO TECHN REP SER
[3]   BECH-RAFAELSEN MANIA SCALE AND THE HAMILTON DEPRESSION SCALE - EVALUATION OF HOMOGENEITY AND INTER-OBSERVER RELIABILITY [J].
BECH, P ;
BOLWIG, TG ;
KRAMP, P ;
RAFAELSEN, OJ .
ACTA PSYCHIATRICA SCANDINAVICA, 1979, 59 (04) :420-430
[4]   Effects of obesity on pharmacokinetics - Implications for drug therapy [J].
Cheymol, G .
CLINICAL PHARMACOKINETICS, 2000, 39 (03) :215-231
[5]   WEIGHT AS A RISK FACTOR FOR CLINICAL DIABETES IN WOMEN [J].
COLDITZ, GA ;
WILLETT, WC ;
STAMPFER, MJ ;
MANSON, JE ;
HENNEKENS, CH ;
ARKY, RA ;
SPEIZER, FE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 132 (03) :501-513
[6]   Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM™-p) for longitudinal assessment of bipolar illness [J].
Denicoff, KD ;
Leverich, GS ;
Nolen, WA ;
Rush, AJ ;
McElroy, SL ;
Keck, PE ;
Suppes, T ;
Altshuler, LL ;
Kupka, R ;
Frye, MA ;
Hatef, J ;
Brotman, MA ;
Post, RM .
PSYCHOLOGICAL MEDICINE, 2000, 30 (06) :1391-1397
[7]   Obesity: What mental health professionals need to know [J].
Devlin, MJ ;
Yanovski, SZ ;
Wilson, GT .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (06) :854-866
[8]   Prevalence of obesity and weight change during treatment in patients with bipolar I disorder [J].
Fagiolini, A ;
Frank, E ;
Houck, PR ;
Mallinger, AG ;
Swartz, HA ;
Buysse, DJ ;
Ombao, H ;
Kupfer, DJ .
JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (06) :528-533
[9]  
FAZIO AF, 1977, DHEW PUBLICATION
[10]   Impact of overweight on the risk of developing common chronic diseases during a 10-year period [J].
Field, AE ;
Coakley, EH ;
Spadano, JL ;
Laird, N ;
Dietz, WH ;
Rimm, E ;
Colditz, GA .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (13) :1581-1586